<DOC>
	<DOCNO>NCT02519400</DOCNO>
	<brief_summary>A total 24 healthy Korean male subject receive single oral dose amitriptyline , 25 mg . Subjects enrol study base cytochrome P450 2D6 cytochrome P450 2C19 genotype , serial blood sample do plasma concentration amitriptyline , nortriptyline , metabolite . Various pharmacodynamic marker related adverse event amitriptyline measure serially study .</brief_summary>
	<brief_title>A Genotype Stratification Study Pharmacokinetics Pharmacodynamics Amitriptyline Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>Healthy male volunteer , age 19~45 year The result Body Mass Index ( BMI ) less 19 kg/m2 , 28 kg/m2 Subject ability comprehend study objective , content property study drug participate trial . Voluntarily sign informed consent form Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study History relevant drug allergy clinically significant hypersensitivity reaction . Smoked 10 cigarette day past 3 month Not eligible due reason include laboratory result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>amitriptyline</keyword>
	<keyword>cyp2d6</keyword>
	<keyword>cyp2c19</keyword>
</DOC>